Service Users’ Views and Experiences of Alcohol Relapse Prevention Treatment and Adherence: New Role for Pharmacists?
Authors:
- Ranjita DhitalRDRanjita Dhital
- Rachel ColemanRCRachel Coleman
- Ed DayEDEd Day
- Colin DrummondCDColin Drummond
- Anne Lingford-HughesALAnne Lingford-Hughes
- John MarsdenJMJohn Marsden
- Tom PhillipsTPTom Phillips
- Julia SinclairJSJulia Sinclair
- John StrangJSJohn Strang
- John WeinmanJWJohn Weinman
- Cate WhittleseaCWCate Whittlesea
- Kideshini WidyaratnaKWKideshini Widyaratna
Open Access
- 15 March 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in Alcohol and Alcoholism
- Vol. 57 (5) , 602-608
Abstract
Aims: To understand service users' views and experiences of alcohol relapse prevention medication, views of a telephone behavioural modification intervention delivered by pharmacists and the use of Contingency Management (CM) to support acamprosate adherence following assisted alcohol withdrawal. Methods: Four focus groups were conducted within four alcohol treatment and recovery groups across England (UK), with service users with lived experience of alcohol dependence (26 participants). Semi-structured topic guide was used to explore participants' views and experiences of alcohol relapse prevention medication, a telephone behavioural modification medication intervention delivered by pharmacists, and the use of CM to support acamprosate adherence. These were audio-recorded, transcribed verbatim and thematically analysed inductively and deductively. Results: Four themes were identified: concerns about support and availability of alcohol relapse prevention medication; lack of knowledge and understanding about acamprosate treatment; positive perceptions of acamprosate adherence telephone support from pharmacists; and negative perceptions of CM to support acamprosate adherence. There were misunderstandings about acamprosate's mode of action and strong negative beliefs about CM. However, most were positive about pharmacists' new role to support acamprosate adherence. Conclusion: This study highlighted challenges service users face to commence alcohol relapse prevention medication. It appears service users could benefit from a pharmacist-led telephone intervention to improve understanding about acamprosate medication, particularly, if delivered in an engaging and motivating way.Keywords
Funding Information
- National Institute for Health Research (13/86/03)
- National Health Service
- Department of Health and Social Care
This publication has 29 references indexed in Scilit:
- Using the framework method for the analysis of qualitative data in multi-disciplinary health researchBMC Medical Research Methodology, 2013
- Reducing and meta-analysing estimates from distributed lag non-linear modelsBMC Medical Research Methodology, 2013
- BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAPJournal of Psychopharmacology, 2012
- Clinician and service user perceptions of implementing contingency management: A focus group studyDrug and Alcohol Dependence, 2011
- Risky drinking among community pharmacy customers in New Zealand and their attitudes towards pharmacist screening and brief interventionsDrug and Alcohol Review, 2011
- Community pharmacy service users' views and perceptions of alcohol screening and brief interventionDrug and Alcohol Review, 2010
- Improving adherence in patients with alcohol dependence: A new role for pharmacistsAmerican Journal of Health-System Pharmacy, 2007
- Contingency management for treatment of substance use disorders: a meta‐analysisAddiction, 2006
- Using thematic analysis in psychologyQualitative Research in Psychology, 2006
- Relapse Prevention for Alcohol and Drug Problems: That Was Zen, This Is Tao.American Psychologist, 2004